arrow_back Civic Audit
Share share

Homeopathic Drug Regulation: Safety, Quality, and Transparency Act.

This act establishes a distinct regulatory pathway for homeopathic drug products, ensuring continued consumer access while mandating specific safety and quality standards. It requires clear labeling, including a mandatory disclaimer that the product's indications have not been evaluated by the FDA. The law also limits private lawsuits against manufacturers based solely on the lack of clinical trials if labeling requirements are met.
Key points
Homeopathic products are exempt from mandatory FDA premarket approval required for conventional drugs.
Labels must include a prominent statement that the product's indications for use have not been evaluated by the Food and Drug Administration.
Manufacturers must adhere to quality and safety standards defined in the Homeopathic Pharmacopoeia of the United States.
The law limits private lawsuits against manufacturers for false advertising based solely on the lack of clinical trials, provided labeling is compliant.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_7050
Sponsor: Rep. Sessions, Pete [R-TX-17]
Process start date: 2026-01-14